Yan Peng

4.3k total citations
96 papers, 2.8k citations indexed

About

Yan Peng is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Yan Peng has authored 96 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Oncology, 30 papers in Molecular Biology and 28 papers in Cancer Research. Recurrent topics in Yan Peng's work include Breast Cancer Treatment Studies (17 papers), Breast Lesions and Carcinomas (16 papers) and HER2/EGFR in Cancer Research (14 papers). Yan Peng is often cited by papers focused on Breast Cancer Treatment Studies (17 papers), Breast Lesions and Carcinomas (16 papers) and HER2/EGFR in Cancer Research (14 papers). Yan Peng collaborates with scholars based in United States, China and Japan. Yan Peng's co-authors include Dengfeng Cao, Venetia Sarode, Robert W. Allan, Kyle Molberg, Robert J. Alpern, Masashi Yanagisawa, Tzong‐Shinn Chu, Orson W. Moe, Patricia A. Preisig and Nisha Unni and has published in prestigious journals such as Cell, Journal of Clinical Investigation and Gastroenterology.

In The Last Decade

Yan Peng

94 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yan Peng United States 34 1.3k 889 751 584 522 96 2.8k
Yoshiyuki Fujiwara Japan 31 1.1k 0.9× 760 0.9× 683 0.9× 844 1.4× 715 1.4× 82 2.6k
Debra Hawes United States 27 1.0k 0.8× 1.1k 1.2× 656 0.9× 391 0.7× 543 1.0× 71 2.7k
Risto Kerkelä Finland 31 2.0k 1.6× 1.1k 1.2× 336 0.4× 536 0.9× 621 1.2× 86 4.6k
Shingo Tsuji Japan 26 1.1k 0.8× 519 0.6× 407 0.5× 509 0.9× 369 0.7× 78 2.7k
Iacopo Sardi Italy 27 988 0.8× 614 0.7× 618 0.8× 386 0.7× 414 0.8× 132 3.1k
Luca Messerini Italy 35 1.0k 0.8× 1.1k 1.3× 467 0.6× 889 1.5× 729 1.4× 113 3.7k
Jan Oosting Netherlands 32 1.1k 0.8× 767 0.9× 673 0.9× 250 0.4× 468 0.9× 73 2.5k
Kazuyuki Ishida Japan 33 799 0.6× 1.1k 1.2× 389 0.5× 1.1k 1.9× 795 1.5× 190 3.4k
Zhaohui Jin United States 27 1.3k 1.0× 1.1k 1.3× 466 0.6× 420 0.7× 585 1.1× 138 3.0k
Mitsutoshi Nakamura Japan 38 2.4k 1.9× 1.1k 1.2× 849 1.1× 398 0.7× 565 1.1× 151 4.5k

Countries citing papers authored by Yan Peng

Since Specialization
Citations

This map shows the geographic impact of Yan Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Peng more than expected).

Fields of papers citing papers by Yan Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Peng. The network helps show where Yan Peng may publish in the future.

Co-authorship network of co-authors of Yan Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Yan Peng. A scholar is included among the top collaborators of Yan Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan Peng. Yan Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Fangfang, Yu Yan, Wei Wei Chen, et al.. (2025). CXCL13 as a Prognostic Biomarker and Modulator of the Tumor Microenvironment in Colorectal Cancer. Journal of Digestive Diseases. 26(7-8). 334–347. 1 indexed citations
2.
Zhu, Yanting, You‐Zhi Zhang, Li Liang, et al.. (2025). Total glucosides of paeony ameliorates lupus nephritis by suppressing ZBP1-mediated PANoptosis in podocytes. Phytomedicine. 145. 156996–156996. 1 indexed citations
3.
Herrera, L, Pravat Kumar Parida, Suvranil Ghosh, et al.. (2024). AXL/WRNIP1 Mediates Replication Stress Response and Promotes Therapy Resistance and Metachronous Metastasis in HER2+ Breast Cancer. Cancer Research. 84(5). 675–687. 7 indexed citations
4.
Wu, Yun, Constance T. Albarracin, Lavinia P. Middleton, et al.. (2024). A Comparative Evaluation of TRPS1 and GATA3 in adenoid cystic, secretory, and acinic cell carcinomas of the breast and salivary gland. Human Pathology. 145. 42–47. 7 indexed citations
5.
Bean, Gregory R., Christopher J. Schwartz, Poonam Vohra, et al.. (2024). Targeted DNA Sequencing in Diagnosis of Malignant Phyllodes Tumors With Emphasis on Tumors With Keratin and p63 Expression. Modern Pathology. 37(12). 100593–100593. 6 indexed citations
6.
Peng, Yan, et al.. (2022). Update on prognostic and predictive biomarkers of breast cancer. Seminars in Diagnostic Pathology. 39(5). 322–332. 37 indexed citations
7.
He, Lin, Ellen Araj, & Yan Peng. (2021). HER2 Positive and HER2 Negative Classical Type Invasive Lobular Carcinomas: Comparison of Clinicopathologic Features. Current Oncology. 28(3). 1608–1617. 4 indexed citations
8.
Liao, Chengheng, Yang Zhang, Cheng Fan, et al.. (2020). Identification of BBOX1 as a Therapeutic Target in Triple-Negative Breast Cancer. Cancer Discovery. 10(11). 1706–1721. 49 indexed citations
9.
Selim, M. Angélica, Yan Peng, Gemma Tell‐Martí, et al.. (2018). Prognostic role of tumoral PDL1 expression and peritumoral FoxP3+ lymphocytes in vulvar melanomas. Human Pathology. 73. 176–183. 20 indexed citations
10.
Liu, Ying, Yazhen Zhu, Yan Peng, et al.. (2016). [Comparison of droplet digital PCR and IHC combined FISH in detection of breast carcinoma HER2 amplification].. PubMed. 45(2). 117–9. 1 indexed citations
11.
Koduru, Prasad, et al.. (2015). Quantification of Human Epidermal Growth Factor Receptor 2 Immunohistochemistry Using the Ventana Image Analysis System. The American Journal of Surgical Pathology. 39(5). 624–631. 15 indexed citations
13.
Huang, Yun, et al.. (2011). [Effect of plasma of healthy subjects undergoing moxibustion on ethanol-injured human gastric epithelial GES-1 cells in vitro and the involved mitochondrial apoptosis pathway].. PubMed. 36(3). 157–63, 192. 3 indexed citations
14.
Sarode, Venetia, David Euhus, Matthew P. Thompson, & Yan Peng. (2011). Atypical Endosalpingiosis in Axillary Sentinel Lymph Node: A Potential Source of False-Positive Diagnosis of Metastasis. The Breast Journal. 17(6). 672–673. 5 indexed citations
15.
Wang, Ke, et al.. (2010). Expression of polycomb protein EZH2 in multi‐stage tissues of gastric carcinogenesis. Journal of Digestive Diseases. 11(2). 88–93. 19 indexed citations
16.
Zhou, Wen, Qian Cao, Yan Peng, et al.. (2009). FoxO4 Inhibits NF-κB and Protects Mice Against Colonic Injury and Inflammation. Gastroenterology. 137(4). 1403–1414. 113 indexed citations
17.
Liu, Aijun, Robert W. Allan, Zhaoli Lane, et al.. (2009). Diagnostic utility of SALL4 in primary germ cell tumors of the central nervous system: a study of 77 cases. Modern Pathology. 22(12). 1628–1636. 57 indexed citations
18.
Peng, Yan & Helen H. Wang. (2006). Impact of reflex HPV testing on interpretation and management of ThinPrep Pap tests. Diagnostic Cytopathology. 34(8). 585–588. 2 indexed citations
19.
Yang, Wenzhuo, Minde Zeng, Yimin Mao, et al.. (2002). [Prophylactic and therapeutic effect of oxymatrine on D-galactosamine-induced rat liver fibrosis].. PubMed. 10(3). 193–6. 21 indexed citations
20.
Chu, Tzong‐Shinn, Yan Peng, A Cano, Masashi Yanagisawa, & Robert J. Alpern. (1996). Endothelin(B) receptor activates NHE-3 by a Ca2+-dependent pathway in OKP cells.. Journal of Clinical Investigation. 97(6). 1454–1462. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026